Related Experiment Video
Updated: Aug 12, 2026

Morris Water Maze Test: Optimization for Mouse Strain and Testing Environment
Published on: June 22, 2015
Let-7d-5p improves mouse cognitive function by targeting bach1 in Alzheimer's disease
1Department of Geriatrics, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430074, China.
Background:
MicroRNAs (miRNAs) have emerged as critical modulators in Alzheimer's disease (AD) pathogenesis. The lethal-7 (let-7) family functions as key regulators of cell apoptosis, differentiation, and immune response. Herein, we explore the functions and underlying mechanisms of let-7d-5p in AD progression.
Methods:
Eight-month-old male APP/PS1 transgenic mice and wild-type C57BL/6 J mice were assigned to the model and control groups, respectively. Model mice received intrahippocampal injections of either a negative control adenovirus (Ad-NC) or a let-7d-5p overexpression adenovirus (Ad-let-7d-5p). The Morris water maze test was conducted to assess cognitive function. Hippocampal histopathological changes were evaluated using hematoxylin and eosin staining. Aβ deposition was detected via immunohistochemical staining. SH-SY5Y cells were transfected with let-7d-5p mimics prior to treatment with 10 μM Aβ1-42. Cell viability and apoptosis were examined using MTT assays and flow cytometry. The expression levels of let-7d-5p and bach1 were measured using RT-qPCR. Western blotting was conducted to evaluate bach1, Bcl-2, and cleaved caspase-3 protein levels. The binding relationship between let-7d-5p and bach1 was verified using luciferase reporter assays.
Results:
In vitro, Aβ1-42 treatment induced the downregulation of let-7d-5p and decrease of cell viability. However, overexpression of let-7d-5p significantly increased let-7d-5p level, enhanced cell viability and inhibited cell apoptosis of Aβ1-42-treated SH-SY5Y cells. Moreover, overexpression of let-7d-5p upregulated Bcl-2 protein levels and downregulated cleaved caspase-3 protein levels in Aβ1-42-treated SH-SY5Y cells. Furthermore, let-7d-5p overexpression ameliorated oxidative stress injury in Aβ1-42-treated SH-SY5Y cells. Importantly, bach1 upregulation counteracted the inhibitory effects of let-7d-5p overexpression on Aβ1-42-induced cellular injury. In vivo, let-7d-5p overexpression mitigated cognitive deficits of AD mice, as indicated by reduced escape latency and increased platform crossings. Additionally, let-7d-5p overexpression attenuated hippocampal histopathological changes and Aβ deposition in APP/PS1 mice. At the molecular level, let-7d-5p targeted bach1 3'UTR and repressed its mRNA and protein expression in vitro and in vivo. Rescue assays further validated that bach1 overexpression restored the protective effect of let-7d-5p on cognitive deficits and pathological injuries.
Conclusion:
Let-7d-5p alleviates cognitive deficits in AD by inhibiting Aβ deposition and neuronal apoptosis through targeting bach1.
Insights
MicroRNAs (miRNAs) are key in Alzheimer's disease (AD). Let-7d-5p, a specific miRNA, alleviates AD symptoms by targeting bach1, reducing Aβ deposition and neuronal apoptosis.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are critical regulators in Alzheimer's disease (AD) pathogenesis.
- The lethal-7 (let-7) family, including let-7d-5p, plays a role in cell apoptosis, differentiation, and immune response.
- Understanding let-7d-5p's function in AD is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the role and mechanisms of let-7d-5p in Alzheimer's disease progression.
- To determine if let-7d-5p can ameliorate Aβ-induced neurotoxicity and cognitive deficits.
- To elucidate the molecular targets and pathways regulated by let-7d-5p in AD.
Main Methods:
- Utilized APP/PS1 transgenic mice and SH-SY5Y neuroblastoma cells.
- Administered let-7d-5p overexpression via adenovirus vectors in vivo and in vitro.
- Assessed cognitive function using the Morris water maze test and evaluated neuropathology via H&E and Aβ immunohistochemistry.
- Measured cell viability, apoptosis, and protein expression (bach1, Bcl-2, cleaved caspase-3) using MTT assays, flow cytometry, RT-qPCR, and Western blotting.
- Verified let-7d-5p and bach1 interaction using luciferase reporter assays.
Main Results:
- Overexpression of let-7d-5p enhanced cell viability, inhibited apoptosis, and reduced oxidative stress in Aβ1-42-treated cells.
- let-7d-5p overexpression improved cognitive function, attenuated hippocampal pathology, and decreased Aβ deposition in AD mice.
- let-7d-5p directly targets bach1, repressing its expression and counteracting Aβ-induced cellular injury and cognitive deficits.
- Bach1 upregulation reversed the protective effects of let-7d-5p, confirming bach1 as a key mediator.
Conclusions:
- Let-7d-5p exerts neuroprotective effects in Alzheimer's disease.
- let-7d-5p alleviates cognitive deficits and neuropathology by inhibiting Aβ deposition and neuronal apoptosis.
- The therapeutic potential of let-7d-5p in AD is mediated through its targeting of the bach1 pathway.
More Related Videos
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
07:07Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Dementia l: Introduction